564 results
Page 2 of 29
8-K
EX-99.1
gxh53kh5 wn2gn
7 Nov 22
Ligand Reports Third Quarter 2022 Financial Results
4:04pm
8-K
EX-10.1
cgl8o03f9sc
4 Nov 22
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:08pm
425
kyxwctnhv8dh zm
3 Oct 22
Business combination disclosure
9:20am
8-K
lk218pqy604qq9
3 Oct 22
Ligand Announces Record Date and Details for Distribution for OmniAb Spin-Off
9:18am
8-K
EX-99.1
bd2136lihl2sy0znl5ud
3 Oct 22
Ligand Announces Record Date and Details for Distribution for OmniAb Spin-Off
9:18am
S-3ASR
EX-4.3
gjfr3zh83 tg
30 Sep 22
Automatic shelf registration
4:17pm
S-3ASR
EX-23.1
t3152bz9awmuoyazd4c
30 Sep 22
Automatic shelf registration
4:17pm
S-3ASR
EX-1.2
8fasrzw6n nigb4tkwo
30 Sep 22
Automatic shelf registration
4:17pm
S-3ASR
offa 9wbfbhu8zpytzr
30 Sep 22
Automatic shelf registration
4:17pm
S-8
mv19q jxd3t
10 Aug 22
Registration of securities for employees
4:05pm
S-8
EX-23.1
qng7ssiwssmrtz52
10 Aug 22
Registration of securities for employees
4:05pm
8-K
0zrqp6ho0eko
29 Jun 22
Ligand Pharmaceuticals Appoints Jason Haas to its Board of Directors
5:17pm
425
EX-99.1
f1a84d0
21 Jun 22
Business combination disclosure
8:00am
8-K
EX-99.1
soqnhg2y
21 Jun 22
Regulation FD Disclosure
6:19am